EverSource Wealth Advisors’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$76.6K Sell
2,788
-1,809
-39% -$48.1K ﹤0.01% 1528
2026
Q1
$123K Buy
4,597
+1,565
+52% +$46.9K ﹤0.01% 1307
2025
Q4
$93.4K Buy
3,032
+854
+39% +$26.6K ﹤0.01% 1356
2025
Q3
$66.8K Buy
2,178
+64
+3% +$1.56K ﹤0.01% 1492
2025
Q2
$43.7K Buy
2,114
+1,174
+125% +$24.1K ﹤0.01% 1709
2025
Q1
$18.4K Sell
940
-317
-25% -$6.65K ﹤0.01% 1733
2024
Q4
$26.2K Buy
1,257
+939
+295% +$20.6K ﹤0.01% 1487
2024
Q3
$7.75K Buy
318
+135
+74% +$3.61K ﹤0.01% 2007
2024
Q2
$5.18K Buy
183
+25
+16% +$709 ﹤0.01% 2213
2024
Q1
$4.38K Buy
158
+42
+36% +$1.23K ﹤0.01% 2102
2023
Q4
$3.69K Sell
116
-158
-58% -$4.96K ﹤0.01% 1979
2023
Q3
$9.66K Buy
274
+10
+4% +$381 ﹤0.01% 1431
2023
Q2
$10K Sell
264
-148
-36% -$5.9K ﹤0.01% 1436
2023
Q1
$15.6K Buy
412
+338
+457% +$13K ﹤0.01% 1182
2022
Q4
$3.14K Buy
74
+22
+42% +$907 ﹤0.01% 1771
2022
Q3
$2K Buy
+52
New +$1.83K ﹤0.01% 1667
2022
Q2
– Sell
-288
Closed -$10K – 1776
2022
Q1
$10K Buy
288
+221
+330% +$7.58K ﹤0.01% 968
2021
Q4
$3K Buy
+67
New +$2.79K ﹤0.01% 1423

Other funds holding GMAB

EverSource Wealth Advisors's GMAB Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Genmab (GMAB) stake by 39% in Q2 2026, selling an estimated $48.1K and leaving 2,788 shares worth $76.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1528.

EverSource Wealth Advisors first reported a position in GMAB in Q4 2021 and has held it in 18 quarters since. The position peaked at $123K in Q1 2026. 291 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • EverSource Wealth Advisors held 2,788 shares of Genmab worth $76.6K as of Q2 2026.
  • EverSource Wealth Advisors sold 1,809 Genmab shares in Q2 2026, an estimated $48.1K.
  • Genmab made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #1528 holding.
  • EverSource Wealth Advisors first reported a position in Genmab in Q4 2021 and has held it in 18 quarters since.
  • EverSource Wealth Advisors's Genmab position peaked at $123K in Q1 2026.
  • 291 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.